Nexentis Technologies (NXTS) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.65, -5.41% vs the prior close of $0.68.
- Volume 38.52K shares, 0.1x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
NXTS slides 5.4% to $0.65, a 52-week low. Closed at $0.65, -5.41% vs the prior close of $0.68. Day range $0.61–$0.71, opened at $0.70.
NXTS daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — NXTS slides 5.4% to $0.65, a 52-week low
- Closed at $0.65, -5.41% vs the prior close of $0.68. Day range $0.61–$0.71, opened at $0.70.
- Volume was 38.52K shares, 0.1x its 50-day average of 422.26K — lighter than usual.
- Price is -57.4% vs its 50-day average ($1.52) and -86.2% vs its 200-day average ($4.67).
- 52-week range $0.60–$30.73; today's close sits at 0% of that range, 97.9% below the 52-week high.
Oct 15, 2026 — NXTS jumps 4.4% to $0.68
- Closed at $0.68, +4.44% vs the prior close of $0.65. Day range $0.60–$0.69, opened at $0.63.
- Volume was 104.40K shares, 0.2x its 50-day average of 421.17K — lighter than usual.
- Price is -55.8% vs its 50-day average ($1.54) and -85.6% vs its 200-day average ($4.72).
- 52-week range $0.60–$32.90; today's close sits at 0% of that range, 97.9% below the 52-week high.
Oct 14, 2026 — NXTS slides 7.2% to $0.65, a 52-week low, 6 down days in a row
- Closed at $0.65, -7.24% vs the prior close of $0.70. Day range $0.60–$0.71, opened at $0.71.
- Volume was 91.10K shares, 0.2x its 50-day average of 422.80K — lighter than usual.
- Price is -58.3% vs its 50-day average ($1.56) and -86.3% vs its 200-day average ($4.78).
- 52-week range $0.60–$32.90; today's close sits at 0% of that range, 98.0% below the 52-week high.
- That makes 6 straight losses.
Oct 13, 2026 — NXTS slides 6.9% to $0.70, a 52-week low, 5 down days in a row
- Closed at $0.70, -6.88% vs the prior close of $0.76. Day range $0.64–$0.75, opened at $0.71.
- Volume was 119.30K shares, 0.3x its 50-day average of 422.91K — lighter than usual.
- Price is -55.8% vs its 50-day average ($1.59) and -85.5% vs its 200-day average ($4.85).
- 52-week range $0.64–$32.90; today's close sits at 0% of that range, 97.9% below the 52-week high.
- That makes 5 straight losses.
Oct 12, 2026 — NXTS slides 11.9% to $0.76, a 52-week low, 4 down days in a row
- Closed at $0.76, -11.89% vs the prior close of $0.86. Day range $0.73–$0.87, opened at $0.87.
- Volume was 315.60K shares, 0.8x its 50-day average of 419.63K.
- Price is -53.3% vs its 50-day average ($1.62) and -84.7% vs its 200-day average ($4.93).
- 52-week range $0.73–$32.90; today's close sits at 0% of that range, 97.7% below the 52-week high.
- That makes 4 straight losses.
Oct 9, 2026 — NXTS dips 2.9% to $0.86, a 52-week low, 3 down days in a row
- Closed at $0.86, -2.94% vs the prior close of $0.88. Day range $0.82–$0.96, opened at $0.82.
- Volume was 176.70K shares, 0.4x its 50-day average of 417.48K — lighter than usual.
- Price is -47.6% vs its 50-day average ($1.64) and -82.9% vs its 200-day average ($5.00).
- 52-week range $0.82–$32.90; today's close sits at 0% of that range, 97.4% below the 52-week high.
- That makes 3 straight losses.
Oct 8, 2026 — NXTS slides 18.1% to $0.88, a 52-week low
- Closed at $0.88, -18.15% vs the prior close of $1.08. Day range $0.88–$1.01, opened at $0.96.
- Volume was 451.60K shares, 1.1x its 50-day average of 409.44K.
- Price is -46.5% vs its 50-day average ($1.65) and -82.6% vs its 200-day average ($5.08).
- 52-week range $0.88–$32.90; today's close sits at 0% of that range, 97.3% below the 52-week high.
Oct 7, 2026 — NXTS slides 22.3% to $1.08, a 52-week low on 346.6x normal volume
- Closed at $1.08, -22.30% vs the prior close of $1.39. Day range $0.94–$1.18, opened at $1.12.
- Volume was 18.42M shares, 346.6x its 50-day average of 53.16K — unusually heavy trading.
- Price is -35.1% vs its 50-day average ($1.66) and -79.1% vs its 200-day average ($5.17).
- 52-week range $0.94–$49.00; today's close sits at 0% of that range, 97.8% below the 52-week high.
Oct 6, 2026 — NXTS rises 0.7% to $1.39
- Closed at $1.39, +0.72% vs the prior close of $1.38. Day range $1.38–$1.41, opened at $1.39.
- Volume was 3.20K shares, 0.1x its 50-day average of 53.76K — lighter than usual.
- Price is -17.0% vs its 50-day average ($1.67) and -73.5% vs its 200-day average ($5.25).
- 52-week range $1.14–$49.00; today's close sits at 1% of that range, 97.2% below the 52-week high.
- SEC filings that day: 8-K.
Oct 5, 2026 — NXTS slides 7.4% to $1.38
- Closed at $1.38, -7.38% vs the prior close of $1.49. Day range $1.37–$1.47, opened at $1.46.
- Volume was 3.50K shares, 0.1x its 50-day average of 54.07K — lighter than usual.
- Price is -17.8% vs its 50-day average ($1.68) and -74.1% vs its 200-day average ($5.33).
- 52-week range $1.14–$49.00; today's close sits at 1% of that range, 97.2% below the 52-week high.
Oct 2, 2026 — NXTS jumps 4.2% to $1.49
- Closed at $1.49, +4.20% vs the prior close of $1.43. Day range $1.41–$1.50, opened at $1.44.
- Volume was 5.30K shares, 0.1x its 50-day average of 54.99K — lighter than usual.
- Price is -11.7% vs its 50-day average ($1.69) and -72.5% vs its 200-day average ($5.42).
- 52-week range $1.14–$49.00; today's close sits at 1% of that range, 97.0% below the 52-week high.
NXTS latest news & SEC filings
Every SEC filing by or about NXTS in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Oct 5, 2026 · Form PRE 14A — Preliminary proxy statement
Preliminary proxy statement
Sep 3, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$11.14M (prior year -$4.51M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$13.66 (prior year -$44.26) (loss narrowed vs Jun 30, 2025)
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 4.01 — Changed its outside auditor.
Jul 17, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Jul 15, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Jul 15, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 13, 2026 · Form S-1 — Registration statement (S-1)
Registration statement (S-1) — registering new shares, usually for an IPO or offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jul 13, 2026 · Form POS AM — POS AM filing
POS AM filing
Jun 23, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jun 22, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 3.02 — Sold unregistered shares.
Things to know before you trade NXTS
- How much it moves: over the last 20 sessions the average daily move was 5.58% (largest 22.3%). That is a volatile stock.
- Liquidity: about 1.02M shares (≈$656.76K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.65 vs a range of $0.60–$30.73 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:7 on Apr 8, 2026, 1:35 on Sep 22, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 4 sales; latest: Eun Young Lee sold 127 shares on Jan 29, 2026.
- Latest filings: 8-K Oct 6, 2026; 8-K Sep 3, 2026; 10-Q Aug 13, 2026.
- Share count: 1.45M shares outstanding (Aug 13, 2026), -95.6% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
NXTS market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.70 | 0.71 | 0.61 | 0.65 | 38.52K |
| Oct 15, 2026 | 0.63 | 0.69 | 0.60 | 0.68 | 104.40K |
| Oct 14, 2026 | 0.71 | 0.71 | 0.60 | 0.65 | 91.10K |
| Oct 13, 2026 | 0.71 | 0.75 | 0.64 | 0.70 | 119.30K |
| Oct 12, 2026 | 0.87 | 0.87 | 0.73 | 0.76 | 315.60K |
| Oct 9, 2026 | 0.82 | 0.96 | 0.82 | 0.86 | 176.70K |
| Oct 8, 2026 | 0.96 | 1.01 | 0.88 | 0.88 | 451.60K |
| Oct 7, 2026 | 1.12 | 1.18 | 0.94 | 1.08 | 18.42M |
| Oct 6, 2026 | 1.39 | 1.41 | 1.38 | 1.39 | 3.20K |
| Oct 5, 2026 | 1.46 | 1.47 | 1.37 | 1.38 | 3.50K |
| Oct 2, 2026 | 1.44 | 1.50 | 1.41 | 1.49 | 5.30K |
| Oct 1, 2026 | 1.41 | 1.46 | 1.41 | 1.43 | 7.20K |
| Sep 30, 2026 | 1.33 | 1.43 | 1.33 | 1.39 | 10.90K |
| Sep 29, 2026 | 1.45 | 1.45 | 1.37 | 1.40 | 7.50K |
| Sep 28, 2026 | 1.45 | 1.50 | 1.45 | 1.47 | 6.80K |
| Sep 25, 2026 | 1.45 | 1.52 | 1.37 | 1.47 | 25.30K |
| Sep 24, 2026 | 1.52 | 1.55 | 1.31 | 1.46 | 74.30K |
| Sep 23, 2026 | 1.43 | 1.66 | 1.14 | 1.46 | 473.50K |
| Sep 22, 2026 | 1.38 | 1.44 | 1.36 | 1.41 | 11.00K |
| Sep 21, 2026 | 1.33 | 1.38 | 1.29 | 1.38 | 13.60K |
About Nexentis Technologies
Nexentis Technologies (NXTS) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in NEW YORK, NY. State of incorporation: NV. Fiscal year ends December 31. SEC CIK 1789192.
NXTS board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Amitay Weiss | Director | Feb 11, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Lital Barda | Chief Financial Officer | Feb 11, 2026 |
| David Palach | Chief Executive Officer | Feb 11, 2026 |
| Shlomo Zakai | Controller | Feb 11, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jan 29, 2026 | Eun Young Lee | Sale | 127 | $1.36 |
| Jan 29, 2026 | Eun Young Lee | Sale | 127 | $1.36 |
| Jan 29, 2026 | Eun Young Lee | Sale | 127 | $1.36 |
| Jan 29, 2026 | Eun Young Lee | Sale | 127 | $1.36 |
NXTS financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-4.00M | -8.61 | $-3.81M |
| Dec 31, 2024 | $210.00K | $-5.19M | -27.74 | $-3.42M |
| Dec 31, 2023 | $263.00K | $-6.52M | -5.43 | $-3.23M |
| Dec 31, 2022 | $394.00K | $-5.74M | 10.85 | $-5.10M |
| Dec 31, 2021 | $438.14K | $-4.82M | — | $-4.11M |
Latest balance sheet: total assets $18.69M, total liabilities $16.91M, cash $7.62M (as of Jun 30, 2026).
NXTS earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on NXTS
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.